|
|
|
|
|
|
|
|
|
|
Mucormycosis: Why Incidence Rate is more in Covid-19 patients Sharma Neha Abhishek* Vice-Principal, Ambaji Nursing College, Ganeshpura, Gujarat *Corresponding Author Email: pandeyn970@gmail.com
Online Published on 03 May, 2025. Abstract This article aims to review existing evidence and evaluate the documented reasons of high association of Mucormycosis with Covis-19 patients. A literature search was conducted using CDC, MedlinePlus, PubMed, Medscape and Researchgate databases. Top Keywords Mucormycosis, Diabetic ketoacidosis, Antifungal medications, Covid-19. Top | |
|
|
|
|
║ Site map
║
Privacy Policy ║ Copyright ║ Terms & Conditions ║
 ║
|
|
|
896,570,642 visitor(s) since 30th May, 2005.
|
|
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
|
|
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.
|